Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
A. Nel, Neliëtte van Niekerk, B. van Baelen, M. Malherbe, Winél Mans, A. Carter, J. Steytler, E. van der Ryst, C. Craig, C. Louw, T. Gwetu, Z. Mabude, P. Kotze, Robert Moraba, H. Tempelman, K. Gill, Sylvia Kusemererwa, L. Bekker, B. Devlin, Z. Rosenberg
The Lancet HIV